HRT Financial’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-48,704
Closed -$2.25M 3921
2025
Q4
$2.25M Buy
+48,704
New +$2.04M 0.01% 1227
2025
Q2
Sell
-41,005
Closed -$1.22M 2752
2025
Q1
$1.22M Sell
41,005
-5,364
-12% -$164K 0.01% 1038
2024
Q4
$1.33M Sell
46,369
-56,282
-55% -$1.86M 0.01% 931
2024
Q3
$3.97M Buy
+102,651
New +$3.66M 0.02% 566
2024
Q2
Sell
-98,586
Closed -$3.83M 2336
2024
Q1
$3.83M Buy
98,586
+49,984
+103% +$1.75M 0.02% 348
2023
Q4
$1.5M Sell
48,602
-42,924
-47% -$1.08M 0.01% 790
2023
Q3
$2.04M Buy
91,526
+12,646
+16% +$288K 0.02% 609
2023
Q2
$1.7M Buy
78,880
+14,015
+22% +$318K 0.02% 682
2023
Q1
$1.56M Buy
+64,865
New +$1.72M 0.02% 726
2022
Q4
Sell
-71,603
Closed -$1.15M 2560
2022
Q3
$1.15M Buy
71,603
+57,469
+407% +$1.01M 0.01% 836
2022
Q2
$250K Sell
14,134
-701
-5% -$11.8K ﹤0.01% 2136
2022
Q1
$302K Sell
14,835
-13,699
-48% -$259K ﹤0.01% 2227
2021
Q4
$533K Buy
+28,534
New +$556K ﹤0.01% 1702
2021
Q3
Sell
-21,774
Closed -$514K 3345
2021
Q2
$514K Buy
+21,774
New +$503K ﹤0.01% 1743
2021
Q1
Sell
-16,681
Closed -$334K 2747
2020
Q4
$334K Buy
+16,681
New +$326K 0.01% 1225

Other funds holding COLL

HRT Financial's COLL Position: Q1 2026 in Review

HRT Financial sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 48,704 shares — an estimated $2.25M sold.

HRT Financial first reported a position in COLL in Q4 2020 and held it in 15 quarters. The position peaked at $3.97M in Q3 2024. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • HRT Financial reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 48,704 Collegium Pharmaceutical shares in Q1 2026, an estimated $2.25M.
  • HRT Financial first reported a position in Collegium Pharmaceutical in Q4 2020 and held it in 15 quarters.
  • HRT Financial's Collegium Pharmaceutical position peaked at $3.97M in Q3 2024.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.